DYNAVAX TECHNOLOGIES CORP DYNAV (0IDA.L) Financials

0IDA.L Assets vs Liabilities

DateAssetsLiabilities
2023-12-31 ? ?
2023-09-30 972.9 million 368.0 million
2023-06-30 936.4 million 359.2 million
2023-03-31 969.9 million 406.2 million

0IDA.L Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-12-31 ? ?
2023-09-30 30.8 million 10.7 million
2023-06-30 27.3 million 10.6 million
2023-03-31 26.3 million 10.0 million

0IDA.L Net Income

Graph available only for supporters. Become a supporter to see it.
DateNet Income
2023-12-31 219000
2023-09-30 14.3 million
2023-06-30 3.4 million
2023-03-31 -24.3 million

0IDA.L Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-12-31 - - -
2023-09-30 720.4 million - -
2023-06-30 681.5 million - -
2023-03-31 652.0 million - -

0IDA.L Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-12-31 ?
2023-09-30 154.2 million
2023-06-30 128.6 million
2023-03-31 127.9 million

0IDA.L Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-12-31 - - - -
2023-09-30 347000 14.1 million - -
2023-06-30 751000 13.0 million - -
2023-03-31 1.3 million 13.6 million - -

0IDA.L Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-12-31 - -
2023-09-30 69.5 million 13.2 million
2023-06-30 60.2 million 13.5 million
2023-03-31 46.9 million 14.7 million

0IDA.L

Price: $11.11

52 week price:
9.50
15.15

Earnings Per Share: 0.75 USD

P/E Ratio: 16.89

Exchange: LSE

Sector: Healthcare

Industry: Pharmaceuticals, Biotechnology & Life Sciences

Market Capitalization: 2.4 million

Links: